183 related articles for article (PubMed ID: 31549021)
1. Treatment of atrial fibrillation in nursing homes: A place for direct acting oral anticoagulants?
Alcusky M; Lapane KL
J Nurs Home Res Sci; 2018; 4():15-19. PubMed ID: 31549021
[TBL] [Abstract][Full Text] [Related]
2. Changes in Anticoagulant Utilization Among United States Nursing Home Residents With Atrial Fibrillation From 2011 to 2016.
Alcusky M; McManus DD; Hume AL; Fisher M; Tjia J; Lapane KL
J Am Heart Assoc; 2019 May; 8(9):e012023. PubMed ID: 31046504
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and the factors associated with oral anticoagulant use among nursing home residents.
Chen Q; Lapane K; Nunes AP; Tjia J; Hugunin J; Alcusky M
J Clin Pharm Ther; 2021 Dec; 46(6):1714-1728. PubMed ID: 34463969
[TBL] [Abstract][Full Text] [Related]
4. Comparative Safety and Effectiveness of Direct-Acting Oral Anticoagulants Versus Warfarin: a National Cohort Study of Nursing Home Residents.
Alcusky M; Tjia J; McManus DD; Hume AL; Fisher M; Lapane KL
J Gen Intern Med; 2020 Aug; 35(8):2329-2337. PubMed ID: 32291717
[TBL] [Abstract][Full Text] [Related]
5. Trends in Anticoagulant Use at Nursing Home Admission and Variation by Frailty and Chronic Kidney Disease Among Older Adults with Atrial Fibrillation.
Campitelli MA; Bronskill SE; Huang A; Maclagan LC; Atzema CL; Hogan DB; Lapane KL; Harris DA; Maxwell CJ
Drugs Aging; 2021 Jul; 38(7):611-623. PubMed ID: 33880747
[TBL] [Abstract][Full Text] [Related]
6. Discontinuation of oral anticoagulant use among nursing home residents with atrial fibrillation before hospice enrollment.
Chen Q; Baek J; Goldberg R; Tjia J; Lapane K; Alcusky M
J Am Geriatr Soc; 2023 Oct; 71(10):3071-3085. PubMed ID: 37466267
[TBL] [Abstract][Full Text] [Related]
7. Geriatric Conditions Are Associated With Decreased Anticoagulation Use in Long-Term Care Residents With Atrial Fibrillation.
Zhang N; Patel J; Chen Z; Zhou Y; Crawford S; McManus DD; Gurwitz J; Shireman TI; Kapoor A
J Am Heart Assoc; 2021 Aug; 10(16):e021293. PubMed ID: 34387127
[TBL] [Abstract][Full Text] [Related]
8. Underuse of oral anticoagulation for individuals with atrial fibrillation in a nursing home setting in France: comparisons of resident characteristics and physician attitude.
Bahri O; Roca F; Lechani T; Druesne L; Jouanny P; Serot JM; Boulanger E; Puisieux F; Chassagne P
J Am Geriatr Soc; 2015 Jan; 63(1):71-6. PubMed ID: 25597559
[TBL] [Abstract][Full Text] [Related]
9. Should nursing home residents with atrial fibrillation be anticoagulated?
Abdel Latif A; Messinger-Rapport BJ
Cleve Clin J Med; 2004 Jan; 71(1):40-4. PubMed ID: 14740967
[TBL] [Abstract][Full Text] [Related]
10. Physician attitudes concerning anticoagulation services in the long-term care setting.
Harrold LR; Gurwitz JH; Tate JP; Becker R; Stuart T; Elwell A; Radford M
J Thromb Thrombolysis; 2002 Aug; 14(1):59-64. PubMed ID: 12652151
[TBL] [Abstract][Full Text] [Related]
11. Warfarin use in nursing home residents: results from the 2004 national nursing home survey.
Ghaswalla PK; Harpe SE; Slattum PW
Am J Geriatr Pharmacother; 2012 Feb; 10(1):25-36.e2. PubMed ID: 22226690
[TBL] [Abstract][Full Text] [Related]
12. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K;
Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
[TBL] [Abstract][Full Text] [Related]
13. Geographic Variation in Anticoagulant Use and Resident, Nursing Home, and County Characteristics Associated With Treatment Among US Nursing Home Residents.
Alcusky M; Baek J; Tjia J; McManus DD; Lapane KL
J Am Med Dir Assoc; 2021 Jan; 22(1):164-172.e9. PubMed ID: 33357746
[TBL] [Abstract][Full Text] [Related]
14. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC
Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081
[TBL] [Abstract][Full Text] [Related]
15. Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex.
Carnicelli AP; Hong H; Connolly SJ; Eikelboom J; Giugliano RP; Morrow DA; Patel MR; Wallentin L; Alexander JH; Cecilia Bahit M; Benz AP; Bohula EA; Chao TF; Dyal L; Ezekowitz M; A A Fox K; Gencer B; Halperin JL; Hijazi Z; Hohnloser SH; Hua K; Hylek E; Toda Kato E; Kuder J; Lopes RD; Mahaffey KW; Oldgren J; Piccini JP; Ruff CT; Steffel J; Wojdyla D; Granger CB;
Circulation; 2022 Jan; 145(4):242-255. PubMed ID: 34985309
[TBL] [Abstract][Full Text] [Related]
16. Net Clinical Benefit of Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Phase III Atrial Fibrillation Trials.
Renda G; di Nicola M; De Caterina R
Am J Med; 2015 Sep; 128(9):1007-14.e2. PubMed ID: 25910790
[TBL] [Abstract][Full Text] [Related]
17. Risks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial Fibrillation.
Shin JI; Secora A; Alexander GC; Inker LA; Coresh J; Chang AR; Grams ME
Clin J Am Soc Nephrol; 2018 Aug; 13(8):1144-1152. PubMed ID: 30002224
[TBL] [Abstract][Full Text] [Related]
18. Use of oral anticoagulants in complex clinical situations with atrial fibrillation.
Gullón A; Sánchez Fuentes D; López-de-Sá E; Martí-Almor J; Barón-Esquivias G; Jiménez López J; Del Mar Contreras Muruaga M; Suárez Fernández C
Med Clin (Barc); 2018 Jun; 150 Suppl 1():8-24. PubMed ID: 30502871
[TBL] [Abstract][Full Text] [Related]
19. Selection of Oral Anticoagulants in Ischemic Stroke Patients with Nonvalvular Atrial Fibrillation.
Deguchi I; Tanahashi N; Takao M
J Stroke Cerebrovasc Dis; 2018 Oct; 27(10):2627-2631. PubMed ID: 29970321
[TBL] [Abstract][Full Text] [Related]
20. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
